Navigation Links
HIV study leads to insights into deadly infection
Date:7/8/2014

Research led by the University of Adelaide has provided new insights into how the HIV virus greatly boosts its chances of spreading infection, and why HIV is so hard to combat.

HIV infects human immune cells by turning the infection-fighting proteins of these cells into a "backdoor key" that lets the virus in. Recent research has found that another protein is involved as well. A peptide in semen that sticks together and forms structures known as "amyloid fibrils" enhances the virus's infection rate by up to an astonishing 10,000 times.

How and why these fibrils enhance infection and cause toxicity in the body's cells remains unknown.

The HIV fibrils known as "semen-derived enhancers of viral infection" (SEVI) have been studied by chemistry and pharmacology researchers at the University of Adelaide. The results of this work have now been published online in the journal Biochimica et Biophysica Acta.

"Amyloid fibrils play an important role in a number of prominent diseases, such as Parkinson's, Alzheimer's and others, and it's absolutely essential that we understand how they work if we have any hope of developing new drugs to stop them," says lead author Dr Ian Musgrave, from the University's School of Medical Sciences.

In laboratory studies, the team found that the HIV fibrils are toxic towards cells from the nervous system. They also found that even when the fibril is broken apart, its constituent elements continue to be toxic.

"This suggests that you can't just prevent one part of SEVI from aggregating and being toxic to cells. You need to shut the whole thing down or stop it from forming in the first place," Dr Musgrave says.

Researchers also tested the fibrils against another major type of body tissue, epithelial cells, and found they were not toxic to these cells.

"Epithelial cells are a major barrier to HIV entry. There have been theories that the fibrils can damage the epithelial layer, making it much easier for the virus to enter the body and infect the immune cells, but our findings show that healthy epithelial cells are resistant," Dr Musgrave says.

"This is an important finding because it could mean that the toxicity from the fibrils is dependent on the type of tissue they come in contact with," Dr Musgrave says.

"We now have a better understanding of the role of these protein enhancers in HIV infection. However, it's clear that much more research is needed in this area," he says.


'/>"/>

Contact: Dr. Ian Musgrave
ian.musgrave@adelaide.edu.au
61-883-133-905
University of Adelaide
Source:Eurekalert

Related biology news :

1. Study reveals fungus in yogurt outbreak poses a threat to consumers
2. New study of largely unstudied mesophotic coral reef geology
3. CWRU and collaborators receive $12.6 million NIH grant to study genetics of Alzheimers
4. Study reveals strong links between Antarctic climate, food web
5. Researchers receive $12.6 million NIH grant to study genetics of Alzheimers
6. Doctoral students to study biology, mechanics connection under NIH grant
7. Insect diet helped early humans build bigger brains, study suggests
8. Flood fear has temporary effect on property prices: QUT study
9. Plants respond to leaf vibrations caused by insects chewing, MU study finds
10. NIH study reveals gene critical to the early development of cilia
11. Study of animal urination could lead to better-engineered products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/16/2016)... , Nov. 16, 2016 Sensory Inc ... and security for consumer electronics, and VeriTran ... and retail industry, today announced a global partnership ... way to authenticate users of mobile banking and ... TrulySecure™ software which requires no specialized biometric ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... Nov. 30, 2016  The Allen Institute for ... the first publicly available collection of gene edited, ... target key cellular structures with unprecedented clarity. Distributed ... powerful tools are a crucial first step toward ... understand what makes human cells healthy and what ...
(Date:11/30/2016)... , Nov. 30, 2016  Tempus, a ... cancer care, and Penn,s Abramson Cancer Center have ... a positive response to immunotherapy treatment based on ... As part of a research collaboration, Tempus ... and melanoma cancer patient data to Penn. Utilizing ...
(Date:11/30/2016)... , 30. November 2016   Merck ... heute die Unterzeichnung einer Reihe von Vereinbarungen ... wird Evotec AG Screeningleistungen für Mercks Palette ... Der Zugriff auf diese Bibliotheken in Kombination ... einen schnelleren Weg zur Ermittlung und Erforschung ...
(Date:11/30/2016)... --  Merck , a leading science and technology company, ... of agreements with Evotec AG, whereby Evotec AG will ... such as CRISPR and shRNA libraries. Combining access to ... pathway to explore and identify new drug targets. ... targets, a process that can be time- and labor-intensive," ...
Breaking Biology Technology: